TRPML1 exhibits high expression in various cancer types, including melanoma [36], pancreatic ductal carcinoma [37], triple negative breast cancer [38], and cancer cells bearing oncogenic HRAS mutations [39]. This evidence concerns the gene HRAS and triple-negative breast carcinoma.